Krishna Vaddi, CEO at Prelude Therapeutics Inc (PRLD), bought 38,376 shares at $5.13 ($197K) on 2022-12-20, disclosed to the SEC on 2022-12-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.13 | 19,188 | $98K | 50.0% |
| 2 | $5.13 | 19,188 | $98K | 50.0% |
| Total | $5.13 avg | 38,376 | $197K | 100% |
| Filing → |
| PRLD | BUY | 2025-03-18 | $29K | — | Filing → |
| PRLD | BUY | 2025-03-14 | $70K | — | Filing → |
| PRLD | BUY | 2025-01-03 | $6K | — | Filing → |